Janus Living (JAN) is down 3.9% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely reason for the decline is Janus Living’s newly priced public stock offering, which adds fresh shares and can pressure the market because of dilution concerns. That appears to be outweighing the company’s otherwise solid second-quarter results and higher full-year guidance from last week.
Details:
Sources:
Janus Living, SEC, Business Wire
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$JAN Insider Trading Activity
$JAN insiders have traded $JAN stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $JAN stock by insiders over the last 6 months:
- SCOTT M BRINKER (PRESIDENT & CEO) purchased 100,000 shares for an estimated $2,000,000
- JOHN V ARABIA purchased 60,000 shares for an estimated $1,200,000
- KATHERINE M SANDSTROM purchased 13,500 shares for an estimated $270,000
- JEFFREY H MILLER (CHIEF OPERATING OFFICER) purchased 7,500 shares for an estimated $150,000
- CHARLES J JR HERMAN purchased 5,500 shares for an estimated $110,000
- DENISE OLSEN purchased 500 shares for an estimated $10,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$JAN Hedge Fund Activity
We have seen 120 institutional investors add shares of $JAN stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 5,607,791 shares (+187.9%) to their portfolio in Q2 2026, for an estimated $161,167,913
- PRUDENTIAL FINANCIAL INC added 3,317,262 shares (+inf%) to their portfolio in Q1 2026, for an estimated $78,187,865
- LONG POND CAPITAL, LP added 3,290,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $77,545,300
- CENTERSQUARE INVESTMENT MANAGEMENT LLC added 2,449,658 shares (+inf%) to their portfolio in Q2 2026, for an estimated $70,403,170
- CITADEL ADVISORS LLC added 1,707,795 shares (+inf%) to their portfolio in Q1 2026, for an estimated $40,252,728
- ALYESKA INVESTMENT GROUP, L.P. added 1,450,500 shares (+inf%) to their portfolio in Q1 2026, for an estimated $34,188,285
- CONVERSANT CAPITAL LLC added 1,210,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $28,519,700
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$JAN Analyst Ratings
Wall Street analysts have issued reports on $JAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Scotiabank issued a "Sector Outperform" rating on 04/14/2026
To track analyst ratings and price targets for $JAN, check out Quiver Quantitative's $JAN forecast page.
$JAN Price Targets
Multiple analysts have issued price targets for $JAN recently. We have seen 11 analysts offer price targets for $JAN in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- Richard Hightower from Barclays set a target price of $33.0 on 07/07/2026
- Nicholas Yulico from Scotiabank set a target price of $29.0 on 06/18/2026
- David Rodgers from Raymond James set a target price of $34.0 on 06/17/2026
- Richard Anderson from Cantor Fitzgerald set a target price of $30.0 on 06/12/2026
- Austin Wurschmidt from Keybanc set a target price of $29.0 on 06/10/2026
- John Kilichowski from Wells Fargo set a target price of $31.0 on 06/01/2026
- Michael Carroll from RBC Capital set a target price of $30.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.